Editorial: Innovation and transformation of chronic airway diseases
Front Mol Biosci
.
2022 Dec 13:9:1089813.
doi: 10.3389/fmolb.2022.1089813.
eCollection 2022.
Authors
Rui Zhao
1
,
Yan Chen
1
,
Yiming Ma
1
,
Chunbin Zou
2
,
Jing Zhang
3
,
Zhihua Chen
4
Affiliations
1
Second Xiangya Hospital, Central South University, Changsha, China.
2
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
3
Zhongshan Hospital, Fudan University, Shanghai, China.
4
Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
PMID:
36582203
PMCID:
PMC9792966
DOI:
10.3389/fmolb.2022.1089813
No abstract available
Keywords:
advances; chronic airway disease; innovation; screening; sulfur compounds.
Publication types
Editorial
Grants and funding
R01 HL142997/HL/NHLBI NIH HHS/United States